Ledger.Open graph →
SEC Form D · filed July 24, 2020

Providence Therapeutics Inc

Offering
$3.5M
Sold
$3.5M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
CALGARY, Alberta, Canada
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Bradley T. Sorenson · Calgary, Alberta, CanadaExec · DirectorKenneth Hughes · Calgary, Alberta, CanadaExecEric Marcusson · San Francisco, CAExecDarlene Haslam · Calgary, Alberta, CanadaExecScott Leary · San Diego, CAExec · DirectorNatalia Orozco · Toronto, Ontario, CanadaExecJennifer White · Dallas, TXExecScott Mcmullin · Los Angeles, CAExecKimberlee Nelson · Dallas, TXExecScott Robinson · Dallas, TXExec · DirectorJohn B. Collis · Boston, MAExec · DirectorNelson Rising · Los Angeles, CAExecRichard W. Scarinci · Boston, MAExec · DirectorWilliam Graff · Newport Coast, CAExecHaiqing Jiang · Mountain View, CAExec · DirectorAntonella Graziano · Luxembourg, LuxembourgExecElisabetta Graff · Newport Coast, CAExecJay Soon · Long Beach, CAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗